Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of PrabotulinumtoxinA for spastic equinus in children with cerebral palsy
TCTR20260510001Phase 4Recruiting
- Sponsor
- N/A
- Start
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in cerebral palsy (CP), Spastic equinus deformity, sponsored by N/A. Started Apr 2026; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)Spastic equinus deformity
Beyond the preview
Go deeper on TCTR20260510001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260510001.